APA (7th ed.) Citation

Larsen, S. L., Laenkholm, A., Duun-Henriksen, A. K., Bak, M., Lykkesfeldt, A. E., & Kirkegaard, T. SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatment. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Larsen, Sarah L., Anne-Vibeke Laenkholm, Anne Katrine Duun-Henriksen, Martin Bak, Anne E. Lykkesfeldt, and Tove Kirkegaard. SRC Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Larsen, Sarah L., et al. SRC Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment. Public Library of Science (PLoS).